Abstract 5067: Concurrent spatial transcriptomics and metabolomics map differential effects of drug across brain cancer tissues

Abstract The spatial heterogeneity of tumors poses significant challenges for effective treatment, resulting in varied therapeutic responses across different regions of the same tumor. This challenge is especially pronounced in brain cancers, where uneven drug distribution—largely due to biological barriers like the blood-brain barrier—complicates treatment. Techniques that overlay drug distribution with transcriptional profiles would enable a comprehensive, unbiased investigation of drug effects. In this study, we present a spatial multiomics approach that integrates spatial metabolomics and spatial transcriptomics within the same tissue section of mouse brain samples treated with Palbociclib, a selective CDK4/6 inhibitor with potential for targeting various cancers, including breast cancer and medulloblastoma (MB). Our high-resolution (2-55 µm) concurrent multiomics maps reveal that the differential distribution of Palbociclib results in heterogeneous effects, promoting differentiation and reducing proliferation in specific tumor regions. Through this approach, we identified tissue regions exhibiting distinct transcriptional and metabolic signatures, including areas unaffected by drug treatment, which could contribute to recurrence. To support this analysis, we developed SpaMTP, a state-of-the-art software package providing a comprehensive pipeline for in-depth analysis of spatial metabolomics for integrating spatial multiomics data. This package bridges processing functionalities for metabolomic data from Cardinal with user-friendly cell-centric analyses implemented in Seurat. SpaMTP’s comprehensive analysis pipeline covers (1) automated mass-to-charge ratio (m/z) metabolite annotation, (2) a wide range of downstream statistical analyses including differential metabolite expression and metabolic pathway analysis, and (3) integrative spatial-omics analysis. For broad implementation and interoperability, SpaMTP includes various functions for data visualisation, data object conversion and data import/export. Overall, our work describes novel experimental and analytical methods to map drug distribution and its transcriptional impacts directly, offering critical insights into the heterogeneous effects of Palbociclib across brain tumor tissues. Citation Format: Tuan Vo, Cedric Cui, Andrew Causer, Xiao Tan, Eunju Kim, Zherui Xiong, Hani Vu, Mark Hodson, Tianyao Lu, Saskia Freytag, Jenny Fung, John Lee, Quan Nguyen. Concurrent spatial transcriptomics and metabolomics map differential effects of drug across brain cancer tissues [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5067.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-5067
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 5067: Concurrent spatial transcriptomics and metabolomics map differential effects of drug across brain cancer tissues

Andrew Causer, Zherui Xiong, Tuan Vo, Cedric S. Cui et al.
Cancer Research
Cancer, Hypoxia, and Metabolism
article

Abstract 5067: Concurrent spatial transcriptomics and metabolomics map differential effects of drug across brain cancer tissues

Andrew Causer, Zherui Xiong, Tuan Vo, Cedric S. Cui, Jenny N. Fung, Mark P. Hodson, Xiao Tan, John D. Lee, Saskia Freytag, Eun Ju Kim, Quan Nguyen, Hani Vu, Tianyao Lu
article en

Abstract

Abstract The spatial heterogeneity of tumors poses significant challenges for effective treatment, resulting in varied therapeutic responses across different regions of the same tumor. This challenge is especially pronounced in brain cancers, where uneven drug distribution—largely due to biological barriers like the blood-brain barrier—complicates treatment. Techniques that overlay drug distribution with transcriptional profiles would enable a comprehensive, unbiased investigation of drug effects. In this study, we present a spatial multiomics approach that integrates spatial metabolomics and spatial transcriptomics within the same tissue section of mouse brain samples treated with Palbociclib, a selective CDK4/6 inhibitor with potential for targeting various cancers, including breast cancer and medulloblastoma (MB). Our high-resolution (2-55 µm) concurrent multiomics maps reveal that the differential distribution of Palbociclib results in heterogeneous effects, promoting differentiation and reducing proliferation in specific tumor regions. Through this approach, we identified tissue regions exhibiting distinct transcriptional and metabolic signatures, including areas unaffected by drug treatment, which could contribute to recurrence. To support this analysis, we developed SpaMTP, a state-of-the-art software package providing a comprehensive pipeline for in-depth analysis of spatial metabolomics for integrating spatial multiomics data. This package bridges processing functionalities for metabolomic data from Cardinal with user-friendly cell-centric analyses implemented in Seurat. SpaMTP’s comprehensive analysis pipeline covers (1) automated mass-to-charge ratio (m/z) metabolite annotation, (2) a wide range of downstream statistical analyses including differential metabolite expression and metabolic pathway analysis, and (3) integrative spatial-omics analysis. For broad implementation and interoperability, SpaMTP includes various functions for data visualisation, data object conversion and data import/export. Overall, our work describes novel experimental and analytical methods to map drug distribution and its transcriptional impacts directly, offering critical insights into the heterogeneous effects of Palbociclib across brain tumor tissues. Citation Format: Tuan Vo, Cedric Cui, Andrew Causer, Xiao Tan, Eunju Kim, Zherui Xiong, Hani Vu, Mark Hodson, Tianyao Lu, Saskia Freytag, Jenny Fung, John Lee, Quan Nguyen. Concurrent spatial transcriptomics and metabolomics map differential effects of drug across brain cancer tissues [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5067.

Cancer ResearchVol. 85(8_Supplement_1)
The University of Queensland (AU), The University of Melbourne (AU), QIMR Berghofer Medical Research Institute (AU)
Openalex Percentile: Top 91%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.